CD34+ Humanized NSG-FLT3-IL15 Mice
The CD34 humanized NSG-FLT3-IL15 (F15) mouse is the most comprehensive immune cell mouse model from the Jackson Laboratory to date.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
This transgenic mouse model is the cross of the NSG-FLT3 and NSG-IL15 mouse, expressing a diverse subset of immune cells such as CD3+ T Cells, CD33+ myeloid progenitor cells, CD16-/CD56dim+ mature natural killer cells, CD11c+ conventional dendritic cells, and CD123+ plasmacytoid dendritic cells. This broad diversity of immune cells enables researchers to study the interplay of the immune system in a single mouse model and evaluation of various immune cell engagers in a single model. Off-the-shelf female mice are available at 18-24 weeks of age.
Key Benefits
- CD34 engrafted NSG-F15 mice have high levels of CD3+ T cells, CD33+ myeloid cells, CD16-/CD56dim+ natural killer cells, and both conventional and plasmacytoid dendritic cells in a single model.
Research Applicatons
- Immuno-oncology
- Autoimmune Disorders
- Human Immune Function
- Infectious Disease
- Diabetes
- Oncology
- Stem Cell Biology
Immune system humanized mouse models for efficacy testing
Immune system humanized mice are rapidly becoming the gold-standard for testing immuno-therapeutics. Their ability to provide functional human immune cells and human tumors, provide drug developers with an invaluable opportunity to predict the clinical performance of their lead compounds. Jackson Laboratory's variants are available in several configurations such as, naïve immunodeficient hosts, immune humanized, and/or engrafted with a human tumor. Discover how you can benefit from routinely tested, proof-of-concept, IND-enabled efficacy and safety tested mouse models.
Advancing drug development with natural killer cells
Natural killer cells play a crucial role in drug development, necessitating models in an environment that replicates human physiology. Find out how the NSG-FTL3-IL15 mouse provides researchers with a reliable and physiologically relevant in vivo model for testing novel NK-based therapeutics. This NK-focused mouse model allows accurate assessment of therapeutic potential.
Innovative mouse models for the development of safer therapeutics
Discover how humanized mouse models are revolutionizing drug safety testing, reducing toxicity risks, and paving the way for more effective therapies
